Study on the Effects of Atacicept in Adults with IgA Nephropathy
France- Participants:18–64 years · 65+ years
- Substances:Atacicept
- Sponsor:Vera Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to France3 418 clinical trials in Le Kremlin-Bicetre, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
FranceStudy Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer
FranceStudy on the Effectiveness and Safety of Imipenem, Cilastatin, and XNW4107 for Adults with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
FranceStudy Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment
FranceStudy on Metreleptin for Children Under 6 with Generalized Lipodystrophy and Related Diabetes or High Triglycerides
FranceStudy on the Effect of Salbutamol on Walking Ability in Patients with ALS
FranceStudy on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma
FranceStudy on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
FranceStudy on Azacitidine and Gilteritinib for Adults with Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia
FranceStudy on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
FranceStudy on the Effects of GLPG3667 for Adults with Dermatomyositis
FranceStudy of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Research in this area focuses on bacterial infections, especially severe ear, nose and throat diseases such as idiopathic purulent oedematous sinusitis in adults. The trials are aimed at evaluating whether treatment can improve symptoms and overall patient well-being.
In Kremlin Bicêtre, this work reflects a practical effort to better manage chronic ENT infection-related complaints.
Clinical research here also covers cardiovascular disease in patients hospitalized for septic shock with tachycardia and hypercontractility. The main goal is to evaluate whether controlling heart rate may help improve survival and clinical outcomes.
These trials are designed to clarify whether better cardiovascular support can reduce risk in critically ill patients.
Another key research focus is otorhinolaryngology, with attention on sinusitis and related ENT disorders. The studies are looking at treatment effectiveness and changes in patient-reported symptoms during follow-up.
This area highlights efforts to improve everyday functioning for patients living with ongoing nasal and sinus problems.
Tell us about your condition – we search every trial in Europe and connect you with the right site.